INOVIO PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
INOVIO PHARMACEUTICALS, INC. (INO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $681.63 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $538.84K.
- INOVIO PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $16.15M.
- INOVIO PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $681.63K, a 95.78% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $16.15M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2025-12-31 | $681.63K 10-K · filed 2026-03-12 | |
| 2025-09-30 | $538.84K 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $16.15M 10-K · filed 2026-03-12 | |
| 2024-06-30 | $16.15M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |